Reclipsen28 Day (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Reclipsen drug offered from Teva Pharmaceuticals USA, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Desogestrel and Ethinyl Estradiol |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-01-01 |
END MARKETING DATE: | 0000-00-00 |
Reclipsen 28 Day HUMAN PRESCRIPTION DRUG Details:
Item Description | Reclipsen 28 Day from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2017-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-3304_2dedcd68-1ffd-452a-8f8e-ce5d1be7703a |
PRODUCT NDC: | 0093-3304 |
APPLICATION NUMBER: | ANDA075256 |